Compounds > 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid

Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and thromboxane a2

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with thromboxane a2 in 5 studies

Compound Research Comparison

Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)	Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)	Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)	Studies (thromboxane a2)	Trials (thromboxane a2)	Recent Studies (post-2010) (thromboxane a2)
36	1	1	5,617	224	429

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cooley, AJ; Culham, CA; Frisbie, DD; Grauer, GF; Johnson, HC; Longhofer, SL; Schultz, KT	1
Douglas, FL; Linberg, L; Martin, LL; Piraino, A; Rakhit, A; Schaffer, AV; Singh, K	1
Anderson, CB; Brunt, EM; Mangino, MJ; Von Doersten, P	1
Holladay, CS; Spangelo, BL; Wright, RM	1
Beauchamp, MH; Bernier, SG; Chemtob, S; Gobeil, F; Hou, X; Kanai, K; Lepage, G; Morrow, JD; Roberts, LJ; Taber, DF; Varma, DR	1

Other Studies

5 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and thromboxane a2

Article	Year
Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis. American journal of veterinary research, 1991, Volume: 52, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Concanavalin A; Dinoprostone; Disease Models, Animal; Dogs; Glomerular Filtration Rate; Glomerulonephritis; Immune Complex Diseases; Kidney; Kidney Glomerulus; Male; Pyridines; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase	1991
Pharmacokinetics of CGS 12970 and inhibition of thromboxane synthesis after oral administration in healthy adults. Clinical pharmacology and therapeutics, 1991, Volume: 49, Issue:4 Topics: Administration, Oral; Adult; Blood Proteins; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pyridines; Thromboxane A2; Thromboxane-A Synthase	1991
Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection. The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:1 Topics: Acute Disease; Animals; Dogs; Glomerular Filtration Rate; Graft Rejection; Kidney Transplantation; Prostaglandins; Pyridines; Renal Circulation; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Homologous	1989
Arachidonic acid stimulates interleukin-6 release from rat peritoneal macrophages in vitro: evidence for a prostacyclin-dependent mechanism. Prostaglandins, leukotrienes, and essential fatty acids, 1993, Volume: 49, Issue:6 Topics: Animals; Arachidonic Acid; Epoprostenol; Iloprost; In Vitro Techniques; Interleukin-6; Kinetics; Macrophages, Peritoneal; Male; Prostaglandins, Synthetic; Pyridines; Rats; Thromboxane A2; Thromboxane-A Synthase	1993
2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite. American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 281, Issue:2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Brain; Calcium; Calcium Channel Blockers; Carbazoles; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; F2-Isoprostanes; gamma-Linolenic Acid; Humans; In Vitro Techniques; Microcirculation; Prostaglandin Antagonists; Pyridines; Retinal Vessels; Swine; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents	2001